Astrana Health, Inc. (ASTH) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq
Astrana Health, Inc. (ASTH) stock forecast summary
Our AI ranks Astrana Health, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Astrana Health, Inc. is a mid-cap company with a market capitalization of $2.11B. It ranks number 6 by market capitalization among the 30 Services-Management Consulting Services issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for ASTH is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, ASTH included.
Follow ASTH freeASTH price chart and AI forecast
How ASTH ranks among 4009 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Astrana Health, Inc. (ASTH) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Management Consulting Services peers listed below that report each metric.
Valuation & Market
| Metric | ASTH | Rank |
|---|---|---|
| Market Cap | $2.11B | 6/30 |
| P/E Ratio | 52.06x | 2/11 |
| P/B Ratio | 2.54x | 16/26 |
| Dividend Yield | 0.79% | 7/8 |
| EPS | $0.67 | – |
| Book Value/Share | $14.90 | – |
| Revenue/Share | $68.97 | – |
| FCF/Share | $1.69 | – |
Profitability & Margins
| Metric | ASTH | Rank |
|---|---|---|
| ROE | 4.9% | 13/24 |
| ROA | 1.8% | 15/32 |
| ROIC | 6.5% | 17/29 |
| Gross Margin | 10.4% | 22/24 |
| Operating Margin | 2.6% | 15/30 |
| Net Margin | 1.1% | 16/28 |
| EBT Margin | 1.6% | 16/31 |
| Tax Rate | 34.7% | – |
Financial Health
| Metric | ASTH | Rank |
|---|---|---|
| Current Ratio | 1.23x | 22/33 |
| D/E Ratio | 2.03x | 5/31 |
| Financial Leverage | 2.75x | 7/31 |
| Interest Coverage | 2.4x | 10/30 |
| Working Capital | $172M | 5/33 |
Cash Flow
| Metric | ASTH | Rank |
|---|---|---|
| Operating Cash Flow | $108M | 7/36 |
| Free Cash Flow | $94M | 6/17 |
| Capital Spending | -$13M | 12/17 |
| OCF Growth YoY | -17.4% | 11/15 |
| FCF Growth YoY | -22.2% | 9/13 |
| FCF/Sales | 2.5% | 13/17 |
| CapEx/Sales | 0.3% | 12/17 |
Operational Efficiency
| Metric | ASTH | Rank |
|---|---|---|
| Asset Turnover | 1.68x | 3/25 |
| Receivables Turnover | 8.3x | 8/19 |
| Fixed Assets Turnover | 61.4x | 7/19 |
| Days Sales Outstanding | 44 days | 12/20 |
| Payables Period | 5 days | 19/21 |
Income Statement
| Metric | ASTH | Rank |
|---|---|---|
| Total Revenue | $3.84B | 3/25 |
| Operating Income | $100M | 7/35 |
| Net Income | $40M | 7/32 |
| Cost of Goods Sold | $3.44B | 2/27 |
Dividend & Shareholder Information
| Metric | ASTH | Rank |
|---|---|---|
| Dividends Per Share | $0.30 | – |
| Payout Ratio | 44.8% | 5/7 |
| Shares Outstanding | 56M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $919M | 40.3% of assets |
| Cash & Short-term Investments | $401M | 17.6% of assets |
| Accounts Receivable | $465M | 20.4% of assets |
| Total Liabilities | $1.68B | 73.8% of assets |
| Short-term Debt | $701M | 30.7% of assets |
ASTH quarterly financials and insider trading
Astrana Health, Inc. (ASTH) industry peers
Companies classified under the same SEC industry code as Astrana Health, Inc. (Services-Management Consulting Services): 43 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| ASTH Astrana Health, Inc. | ▲ | $2.11B |
| BAH Booz Allen Hamilton Holding Corp | ▼ | $8.70B |
| G Genpact Ltd | ▼ | $5.92B |
| FCN Fti Consulting, Inc | ▼ | $3.81B |
| EXPO Exponent Inc | ▲ | $3.39B |
| HURN Huron Consulting Group Inc. | ▼ | $2.86B |
| ICFI Icf International, Inc. | ▼ | $1.57B |
| BWMN Bowman Consulting Group Ltd. | ▼ | $741M |
| RMR Rmr Group Inc. | ▲ | $588M |
| ROMA Roma Green Finance Ltd | ▶ | $504M |
| ONT Onterris, Inc. | ▲ | $466M |
| PPHC Public Policy Holding Company, Inc. | ▲ | $320M |
| HCKT Hackett Group, Inc. | ▲ | $286M |
| III Information Services Group Inc. | ▲ | $285M |
| TSSI Tss, Inc. | ▲ | $249M |
| PHCI Panamera Holdings Corp | ▼ | $169M |
| MHH Mastech Digital, Inc. | ▶ | $78M |
| GFLT Genflat Holdings, Inc. | ▼ | $69M |
| CTM Castellum, Inc. | ▲ | $56M |
| VDTA Vertical Data Inc. | ▼ | $56M |
| EUBG Entrepreneur Universe Bright Group | ▼ | $43M |
| AERT Aeries Technology, Inc. | ▲ | $32M |
| RYOJ Ryojbaba Co., Ltd. | ▶ | $32M |
| ACCS Access Newswire Inc. | ▼ | $18M |
| GRNQ Greenpro Capital Corp. | ▼ | $14M |
| PBSV Pharma-Bio Serv, Inc. | ▶ | $10M |
| CISO Ciso Global, Inc. | ▲ | $7M |
| ELVG Elvictor Group, Inc. | ▲ | $5M |
| BDTB Bodhi Tree Biotechnology Inc | ▼ | $5M |
| HSTA Hestia Insight Inc. | ▼ | $840K |
| AUC Atif Holdings Ltd | ▼ | N/A |
| DFNS T3 Defense Inc. | ▶ | N/A |
| GIB Cgi Inc | ▼ | N/A |
| GXXM Gex Management, Inc. | ▶ | N/A |
| IVHI Invech Holdings, Inc. | ▶ | N/A |
| LEEN Leopard Energy, Inc. | ▼ | N/A |
| LICN Lichen International Ltd | ▼ | N/A |
| NORD Nordicus Partners Corp | ▲ | N/A |
| RTB Rtb Digital, Inc. | ▲ | N/A |
| SATT Sativus Tech Corp. | ▼ | N/A |
| SSHT Ssht S&T Group Ltd. | ▼ | N/A |
| THRC Havana Roasters Coffee Companies, Inc. | ▼ | N/A |
| WYGC Wenyuan Group Corp. | ▼ | N/A |
Where ASTH sits on the market map
Astrana Health, Inc. (ASTH) stock news
Loading...
Astrana Health, Inc. (ASTH) stock forecast FAQ
What is the Astrana Health, Inc. (ASTH) stock forecast?
Our AI ranks Astrana Health, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Astrana Health, Inc. stock predictions?
A per-ticker accuracy statistic for ASTH is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Astrana Health, Inc. forecasts updated?
Astrana Health, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Astrana Health, Inc.'s industry peers?
43 issuers in our coverage, ASTH included, share the SEC industry code Services-Management Consulting Services. The largest are: Booz Allen Hamilton Holding Corp (BAH), Genpact Ltd (G), Fti Consulting, Inc (FCN), Exponent Inc (EXPO), Huron Consulting Group Inc. (HURN), Icf International, Inc. (ICFI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.